Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minal Patel

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
Cancer Discovery|October 18, 2014
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersDavid M Hyman, Eli L Diamond, Cecile Rose T Vibat, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Science Translational Medicine|May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemiaStephen S Chung, Eunhee Kim, Jae H Park, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Large-scale multi-omic analysis identifies noncoding somatic driver mutations and nominates <i>ZFP36L2</i> as a driver gene for pancreatic ductal adenocarcinomaJun Zhong, Aidan O'Brien, Minal Patel, et al.
Nature Communications|February 23, 2016
MSI2 is required for maintaining activated myelodysplastic syndrome stem cellsJames Taggart, Tzu-Chieh Ho, Elianna Amin, et al.
Blood|September 2, 2020
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemiaWenbin Xiao, Alexander Chan, Michael R Waarts, et al.
American Journal of Hematology|October 2, 2019
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myelomaEven H Rustad, Kristine Misund, Elsa Bernard, et al.
Communications Medicine|January 12, 2026
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohortMajd Al Assaad, Kevin Hadi, Max F Levine, et al.
Bioinformatics (Oxford, England)|March 14, 2024
ArCH: improving the performance of clonal hematopoiesis variant calling and interpretationIrenaeus C C Chan, Alex Panchot, Evelyn Schmidt, et al.
Nature|June 29, 2018
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutationsAndrew M Intlekofer, Alan H Shih, Bo Wang, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Cancer Discovery|October 18, 2014
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersDavid M Hyman, Eli L Diamond, Cecile Rose T Vibat, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Science Translational Medicine|May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemiaStephen S Chung, Eunhee Kim, Jae H Park, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Large-scale multi-omic analysis identifies noncoding somatic driver mutations and nominates <i>ZFP36L2</i> as a driver gene for pancreatic ductal adenocarcinomaJun Zhong, Aidan O'Brien, Minal Patel, et al.
Nature Communications|February 23, 2016
MSI2 is required for maintaining activated myelodysplastic syndrome stem cellsJames Taggart, Tzu-Chieh Ho, Elianna Amin, et al.
Blood|September 2, 2020
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemiaWenbin Xiao, Alexander Chan, Michael R Waarts, et al.
American Journal of Hematology|October 2, 2019
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myelomaEven H Rustad, Kristine Misund, Elsa Bernard, et al.
Communications Medicine|January 12, 2026
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohortMajd Al Assaad, Kevin Hadi, Max F Levine, et al.
Bioinformatics (Oxford, England)|March 14, 2024
ArCH: improving the performance of clonal hematopoiesis variant calling and interpretationIrenaeus C C Chan, Alex Panchot, Evelyn Schmidt, et al.
Nature|June 29, 2018
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutationsAndrew M Intlekofer, Alan H Shih, Bo Wang, et al.
Pageof 21